CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.
Similar Posts
Search List of Extended Use Dates to Assist with Drug Shortages
This is to update and consolidate the extended use date information posted previously to assist with drug shortage (6/15/17 to present).Oncology (Cancer)/Hematologic Malignancies Approval Notifications
FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the latest approvals and prescribing information for specific products.Zydus Lifesciences Limited – 9/5/2025
Zydus Lifesciences Limited – 9/5/2025. Country: India. Record Type: 483HerbsForever LLC Issues Allergy Alert on Undeclared Wheat in HerbsForever brand Dietary Supplements
01/07/2026 – HerbsForever LLC of Los Angeles, California is recalling 45 units of the product “Hingwastik Churna” and 45 units of “Gastro Care” dietary supplements because they may contain undeclared wheat. People who have a wheat allergy run a risk of serious or life-threatening allergic reactionsGeneric Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.Office of Generic Drugs | Offices and Divisions
Generic Drugs Offices and Divisions